After reportedly flirting with going public for years, the artificial intelligence-powered drug developer Insilico Medicine has laid out plans to raise about $292 million through a listin | The IPO filing wraps up a year that saw Insilico raise $110 million in venture capital and sign multiple R&D deals with global drugmakers. https://www.fiercebiotech....